253 related articles for article (PubMed ID: 24870597)
1. MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.
Kaymaz BT; Cetintaş VB; Aktan C; Kosova B
Tumour Biol; 2014 Sep; 35(9):8733-42. PubMed ID: 24870597
[TBL] [Abstract][Full Text] [Related]
2. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
Kaymaz BT; Günel NS; Ceyhan M; Çetintaş VB; Özel B; Yandım MK; Kıpçak S; Aktan Ç; Gökbulut AA; Baran Y; Can BK
Tumour Biol; 2015 Sep; 36(10):7915-27. PubMed ID: 25953263
[TBL] [Abstract][Full Text] [Related]
3. LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway.
Zhang B; Yu L; Han N; Hu Z; Wang S; Ding L; Jiang J
Biomed Pharmacother; 2018 Nov; 107():270-282. PubMed ID: 30098545
[TBL] [Abstract][Full Text] [Related]
4. Repression of STAT3, STAT5A, and STAT5B expressions in chronic myelogenous leukemia cell line K-562 with unmodified or chemically modified siRNAs and induction of apoptosis.
Kaymaz BT; Selvi N; Gündüz C; Aktan C; Dalmızrak A; Saydam G; Kosova B
Ann Hematol; 2013 Jan; 92(2):151-62. PubMed ID: 23053176
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
Bi CL; Zhang YQ; Li B; Guo M; Fu YL
J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
[TBL] [Abstract][Full Text] [Related]
6. STAT3 Mediated miR-30a-5p Inhibition Enhances Proliferation and Inhibits Apoptosis in Colorectal Cancer Cells.
Cheng CC; Yang BL; Chen WC; Ho AS; Sie ZL; Lin HC; Chang CC
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023006
[TBL] [Abstract][Full Text] [Related]
7. miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1.
Nie ZY; Liu XJ; Zhan Y; Liu MH; Zhang XY; Li ZY; Lu YQ; Luo JM; Yang L
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962263
[TBL] [Abstract][Full Text] [Related]
8. Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance.
Wu YY; Lai HF; Huang TC; Chen YG; Ye RH; Chang PY; Lai SW; Chen YC; Lee CH; Liu WN; Dai MS; Chen JH; Ho CL; Chiu YL
Cell Death Dis; 2021 Oct; 12(10):908. PubMed ID: 34611140
[TBL] [Abstract][Full Text] [Related]
9. MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein.
Hershkovitz-Rokah O; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Raanani P; Shpilberg O; Granot G
Cancer Lett; 2015 Jan; 356(2 Pt B):597-605. PubMed ID: 25305453
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
[TBL] [Abstract][Full Text] [Related]
12. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
Farhadi E; Zaker F; Safa M; Rezvani MR
Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
[TBL] [Abstract][Full Text] [Related]
13. Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells.
Ma LD; Zhou M; Wen SH; Ni C; Jiang LJ; Fan J; Xia L
Leuk Lymphoma; 2010 Jul; 51(7):1326-36. PubMed ID: 20497005
[TBL] [Abstract][Full Text] [Related]
14. Effect and mechanism of miR-135a-5p/CXCL12/JAK-STAT axis on inflammatory response after myocardial infarction.
Guo XY; Liu QL; Liu W; Cheng JX; Li ZJ
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12912-12928. PubMed ID: 33378042
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.
Shen N; Huang X; Li J
Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305
[TBL] [Abstract][Full Text] [Related]
16. De-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses CML cell apoptosis and contributes to Imatinib resistance.
Nie ZY; Yao M; Yang Z; Yang L; Liu XJ; Yu J; Ma Y; Zhang N; Zhang XY; Liu MH; Jiang LL; Luo JM
J Exp Clin Cancer Res; 2020 Jan; 39(1):17. PubMed ID: 31952546
[TBL] [Abstract][Full Text] [Related]
17. Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.
Salati S; Salvestrini V; Carretta C; Genovese E; Rontauroli S; Zini R; Rossi C; Ruberti S; Bianchi E; Barbieri G; Curti A; Castagnetti F; Gugliotta G; Rosti G; Bergamaschi M; Tafuri A; Tagliafico E; Lemoli R; Manfredini R
Oncotarget; 2017 Jul; 8(30):49451-49469. PubMed ID: 28533480
[TBL] [Abstract][Full Text] [Related]
18. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells.
Venturini L; Battmer K; Castoldi M; Schultheis B; Hochhaus A; Muckenthaler MU; Ganser A; Eder M; Scherr M
Blood; 2007 May; 109(10):4399-405. PubMed ID: 17284533
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-216a exerts neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory pathways.
Tian YS; Zhong D; Liu QQ; Zhao XL; Sun HX; Jin J; Wang HN; Li GZ
J Neurosurg; 2018 Mar; 130(3):977-988. PubMed ID: 29521586
[TBL] [Abstract][Full Text] [Related]
20. Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell line.
Bhutra S; Lenkala D; LaCroix B; Ye M; Huang RS
PLoS One; 2014; 9(12):e115003. PubMed ID: 25506832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
